CTSB and central nervous system cancer: Our study indicates that highly-expressed CTSB in the immune microenvironment is closely correlated with the malignant molecular features, worse prognosis, immune cells infiltration and immunosuppression processes of gliomas, which can be regard as a new prognostic biomarker and potential therapeutic target.